Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, et al.
Nature Metabolism (2021) Vol. 3, Iss. 6, pp. 774-785
Open Access | Times Cited: 356

Showing 1-25 of 356 citing articles:

Pathological sequelae of long-haul COVID
Saurabh Mehandru, Miriam Mérad
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 194-202
Open Access | Times Cited: 583
Risks and burdens of incident diabetes in long COVID: a cohort study
Yan Xie, Ziyad Al‐Aly
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 5, pp. 311-321
Open Access | Times Cited: 456
Diabetes Fact Sheet in Korea 2021
Jae Hyun Bae, Kyungdo Han, Seung‐Hyun Ko, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 3, pp. 417-426
Open Access | Times Cited: 264
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 216
Post-acute COVID-19 syndrome
David Montani, Laurent Savale, Nicolas Noël, et al.
European Respiratory Review (2022) Vol. 31, Iss. 163, pp. 210185-210185
Open Access | Times Cited: 213
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161
Incidence of newly diagnosed diabetes after Covid-19
Wolfgang Rathmann, Oliver Kuß, Karel Kostev
Diabetologia (2022) Vol. 65, Iss. 6, pp. 949-954
Open Access | Times Cited: 154
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
Calvin Ke, K.M. Venkat Narayan, Juliana C.N. Chan, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 413-432
Open Access | Times Cited: 144
Gut Microbiome Alterations in COVID-19
Tao Zuo, Xiaojian Wu, Weiping Wen, et al.
Genomics Proteomics & Bioinformatics (2021) Vol. 19, Iss. 5, pp. 679-688
Open Access | Times Cited: 115
Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms
Grace Kenny, Kathleen McCann, Conor O’Brien, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 4
Open Access | Times Cited: 111
Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100
Long Covid: where we stand and challenges ahead
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 98
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
Jing-Xian Yin, Yannick Luther Agbana, Zhishan Sun, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 89
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Berenice Martínez-Salazar, Melle Holwerda, Chiara Stüdle, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 85
Post-acute sequelae of COVID-19: A metabolic perspective
Philipp E. Scherer, John P. Kirwan, Clifford J. Rosen
eLife (2022) Vol. 11
Open Access | Times Cited: 75
Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 73
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
Raffaele Izzo, Valentina Trimarco, Pasquale Mone, et al.
Pharmacological Research (2022) Vol. 183, pp. 106360-106360
Open Access | Times Cited: 71
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
Sizhen Su, Yi‐Miao Zhao, Na Zeng, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4056-4069
Closed Access | Times Cited: 58
The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019
Junjun Ye, Yixi Wu, Shuhui Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 53
The plasma metabolome of long COVID patients two years after infection
Yamilé López‐Hernández, Joel Monárrez‐Espino, David Alejandro García López, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 50
A sustainable approach to universal metabolic cancer diagnosis
Ruimin Wang, Shouzhi Yang, Mengfei Wang, et al.
Nature Sustainability (2024) Vol. 7, Iss. 5, pp. 602-615
Closed Access | Times Cited: 20
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Diabetes Fact Sheets in Korea 2024
Se Eun Park, Seung‐Hyun Ko, Ji Yoon Kim, et al.
Diabetes & Metabolism Journal (2025) Vol. 49, Iss. 1, pp. 24-33
Open Access | Times Cited: 3
COVID-19–Induced New-Onset Diabetes: Trends and Technologies
Ahmed A. Metwally, Pranav Mehta, Brian S. Johnson, et al.
Diabetes (2021) Vol. 70, Iss. 12, pp. 2733-2744
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top